Skip to content

Report a Typo or Mistake

Optional

Optional

Optional

European committee takes a second look at Alzheimer's drug and now says it should be approved
Verify
push icon
Be the first to read breaking stories. Enable push notifications on your device. Disable anytime.
No thanks